By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.

OK

Akorn and Fresenius Continue to Skirmish Post-Trial

Fresenius asked a Delaware judge Tuesday to allow it to add new evidence to its case seeking court approval to terminate its agreement to acquire Akorn.featured

Akorn/Fresenius: Notes from August 23 Delaware Final Arguments

As of 2:52pm … Judge Laster concluded the trial by saying it’s not an easy case to decide and will take him some time to write an opinion. He said he has 90 days to do so but will try to issue a ruling soon to honor the expeditious fashion both sides used to prepare … Read Morefeatured

Five Essentials from CTFN This Week

A decision in the Aetna/CVS Health merger is likely to come in the next three to six weeks, according to a former assistant section chief in the healthcare and consumer products section within the Department of Justice’s antitrust division. More here … U.S. state insurance department reviews of AXA’s $15.3 billion acquisition of Bermuda-based XL … Read Morefeatured

Year-End Resolution Seen for Akorn/Fresenius Case

A post-trial briefing schedule for the Akorn/Fresenius case was set July 16 that would suggest a final legal resolution of the case around year-end. Under the briefing schedule approved byfeatured

Four Essentials from CTFN This Week

Industrial gas giants Linde and Praxair are in discussions with Latin American regulators for the sale of the overlapping assets that will need to be divested to gain clearance for their planned merger. More here … As the pleading cycle for the Tribune/Sinclair merger comes to a close, it appears unlikely the Federal Communications Commission … Read Morefeatured

Day 5: Akorn v. Fresenius Trial

Day five of the Akorn trial began with Stephan Sturm, CEO and chairman of Fresenius, called to the witness stand and testifying about his “disappointment” at thefeatured

Judge to Weigh Akorn Violations

Fresenius will have one more day to convince a Delaware judge that data integrity violations at Akorn are severe enough to allow the German healthcare giant to back outfeatured

Akorn v. Fresenius: Notes from Day Four of the Trial

Corrected for witness name in updates beginning 12:29pm … Day 4 of the trial began with the lawyer for Fresenius continuing a heated cross-examination of the attorney who conducted Akorn’s internal investigation into the fraudulentfeatured

Day 3: Akorn v. Fresenius

Day three of the Akorn v. Fresenius trial began with the lead attorney for Fresenius cross-examining Akorn CEO Raj Rai about whether Akorn investigatingfeatured

Akorn v. Fresenius Trial: Day 2 Updates

Day two of the Akorn v. Fresenius trial began with a Fresenius attorney working to impeach Monday’s testimony of a compliance expert who testified on behalf of Akorn thatfeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.